Ensuring a future with the greatest possibilities in health technology
innovation begins with securing the future of Stanford Biodesign.

A Message from Paul Yock

Thanks to our community of supporters, Stanford Biodesign has launched a new generation of health technology innovators while sharing our needs-based innovation process around the globe. These amazing Stanford Biodesigners have invented more than 100 medical devices, started dozens of companies, raised hundreds of millions of dollars, taught hundreds of others our unique biodesign innovation process, and helped more than two million patients so far.

Stanford Biodesign has achieved these results with the support of our industry, foundation, and individual donors. We are completely reliant on donations from these sources to run our yearly programs. But this type of funding can be unpredictable. We need long-term support we can depend on to secure the future of Stanford Biodesign. With your philanthropic partnership, we’ll build an endowment that will allow us to expand our horizons beyond each new class of fellows, students, and faculty trainees.

Our designation as the Byers Center for Biodesign is the first step on our journey to a more sustainable future. The next step depends on you. Please help us continue teaching and spreading the biodesign innovation process for generations to come by getting involved today. Together we can educate aspiring innovators and empower them to deliver solutions to the world’s biggest health challenges.

Learn more by taking an in-depth look at who we are, our unique three-step innovation process that works in every setting, and how we're using it to change health care here and around the globe in our online brochure

Ensuring a future with the greatest possibilities in health technology innovation begins with securing the future of Stanford Biodesign. Join us.

Paul G. Yock
Director, Stanford Biodesign


“I’m one of the many volunteers who have worked with Stanford Biodesign. For nearly 15 years, I’ve mentored, coached, and supported fellows and the program. I’ve had the pleasure and honor to get to know Paul Yock and the talented leadership team very well.

I’m thrilled that Stanford Biodesign has earned the designation of a formal ‘Center’ at Stanford. This program is uniquely positioned to improve human health around the world. Their fellows and medical innovations change health care and have already directly benefited hundreds of thousands of patients. And they’re inspiring and empowering others by sharing best practices globally.

– Brook Byers, Partner, Kleiner Perkins Caufield & Byers

Sharing the Vision

Thank You, Cottrell Foundation

The Frederick Gardner Cottrell Foundation provides financial support to educational nonprofits to help technologies developed at universities reach and benefit the public. Although many approaches have been tried, universities still struggle to effectively transfer needed academic innovations to public use. The translation of health technologies is particularly challenging given the complex landscape of stakeholders that must be satisfied in order to bring a new technology to the market.   

In 2020, Stanford Biodesign and Fogarty Innovation, both 501c(3) philanthropic nonprofits, formed a formal collaboration to address the gap between promising health technology projects and their ability to successfully launch as fundable businesses that can deliver these innovations to patients. This collaboration, temporarily titled BFx, links the expertise of the two groups to accelerate high potential projects along their journey to patient care by providing a comprehensive program of intensive education, mentorship, and support. 

We believe the continual engagement of experts with deep experience in the real world of commercialization will significantly expedite the translation of university-developed solutions to important unmet healthcare needs into public use. The Cottrell Foundation saw merit in this approach and has agreed to support this collaboration with a generous $5 million grant over the next five years. 

We are incredibly grateful for this gift. In particular, we would like to thank Christopher P. Martin, President, Medical Devices & Chief Financial Officer of RCT, and Avi Roop, Managing Director of RCT, for their vision and trust in Stanford Biodesign and Fogarty Innovation as we seek to advance Dr. Cottrell’s mission of “science in service of society.”